Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of STAR-101 in Healthy Subjects

NCT04081597 is registered in ClinicalTrials.gov with Acanthas Pharma Inc as lead sponsor.

NCT NCT04081597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04081597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of STAR-101 in Healthy Subjects
Lead sponsor
Acanthas Pharma Inc
Phase
Phase 1
Overall status
Withdrawn
Start date
February 29, 2020
Completion date
March 31, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers